748.8 +4.88 (+0.65%) Buy

Joy for PUNJABCHEM investors as it ranks better than it's peers but, has not managed to breakout

15 min read

PUNJAB CHEM & CROP PROT L showed marginal outperformance today. It increased by +0.65% to close at 748.8. It's recent 5 day performance has been -0.06%, +1.13%, +1.07%, +0.23% and +1.03%.

[Themes containing PUNJABCHEM]

PUNJABCHEM is currently in a bullish trend. The current bullish signal has generated a profit of +22.33% for PUNJABCHEM's investors in the last three months.


PUNJABCHEM has been outperforming the NIFTY-50 index in recent time. It showed significant outperformance (compared to the NIFTY-50 index) from 22 Feb, 2016 to 18 Jan, 2019. One must note that PUNJABCHEM is currently at it's peak outperformance to the NIFTY-50 index which makes it a good investment candidate. Over the last 3 years and 1 month, PUNJABCHEM outperformed the NIFTY-50 index on 49% days. Which indicates that on days PUNJABCHEM outperforms the NIFTY-50 index, it's performance is marginally better than on the days it underperforms the NIFTY-50 index.

During the last three months PUNJABCHEM was mostly profitable and delivered on average +0.47% per day. It's best return during this period (of +7.86%) was on Monday, 29 Oct, 2018. While it's worst loss in the same period (of -3.16%) was on Tuesday, 23 Oct, 2018. The longest stort-term trend during this period was 5 profitable days, which started on 11 Dec, 2018 and went on till 17 Dec, 2018. This bullish trend returned +8.63% to investors.

During the last year PUNJABCHEM had 5 profitable months and 7 loss making months. Profitable number of months of PUNJABCHEM and NIFTY-50 index were the same. PUNJABCHEM significantly outperformed NIFTY-50 index in Jul 2018, when it returned +35.95% compared to +6.56% returned by NIFTY-50 index during it's best month in the last one year - Jul 2018. PUNJABCHEM had a longer winning streak of profitable months than NIFTY-50 index. It went up in 3 straight months (from Nov 2018 to Jan 2019) during which period it delivered +27.06%. It is interesting to note that both PUNJABCHEM and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.

"There can be no rise in the value of labour without a fall of profits.

PUNJABCHEM is currently seeing overall fall in volatility. In comparison, the NIFTY-50 index is seeing decrease in volatility. During the last three months, there was a significant fall in PUNJABCHEM's volatility from 29 Oct, 2018 to 18 Jan, 2019. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that PUNJABCHEM has negative skewness in it's return distribution. This indicates that investors may need to stay invested through long periods of drawdown before expecting a recovery.

NIFTY-50 index has more chance of extreme outcomes than PUNJABCHEM. Therefore, NIFTY-50 must receive a lower allocation than PUNJABCHEM in your portfolio. NIFTY-50 index usually has shorter drawdown period than PUNJABCHEM.

Based on your interest in PUNJABCHEM you may find it interesting to know that APCOTEXIND has delivered similar performance as PUNJABCHEM and can be considered as an alternative investment candidate (to PUNJABCHEM).

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter